Bigul

Alembic Ltd - 506235 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company as per the attached file, have been reported as lost/misplaced and the shareholder of such lost share certificate(s) have requested the Company for issue of duplicate share certificate(s). Also find attached herewith the letter received from RTA as a proof of date of receipt of information by the Company. We request you to kindly take the same on record.
04-02-2020
Bigul

ALEMBIC LTD. - 506235 - Results For The Quarter And Nine Months Period Ended 31St December, 2019

With reference to the captioned subject, the exchange is hereby informed that the Board of Directors of Alembic Limited at its meeting held today has inter alia approved the Unaudited Financial Results of the Company for the quarter and nine months period ended on 31st December, 2019. We enclose herewith the following: 1) Consolidated Unaudited Financial Results of the Company for the quarter and nine months period ended on 31st December, 2019. 2) Standalone Unaudited Financial Results of the Company for the quarter and nine months period ended on 31st December, 2019. 3) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. The time of commencement of the Board Meeting was 12:30 p.m. and the time of conclusion was 13:30 p.m. We request you to kindly take the same on your record.
31-01-2020
Bigul

Alembic Ltd - 506235 - Outcome Of Board Meeting

With reference to the captioned subject, the exchange is hereby informed that the Board of Directors of Alembic Limited at its meeting held today has inter alia approved the Unaudited Financial Results of the Company for the quarter and nine months period ended on 31st December, 2019. We enclose herewith the following: 1) Consolidated Unaudited Financial Results of the Company for the quarter and nine months period ended on 31st December, 2019. 2) Standalone Unaudited Financial Results of the Company for the quarter and nine months period ended on 31st December, 2019. 3) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. The time of commencement of the Board Meeting was 12:30 p.m. and the time of conclusion was 13:30 p.m. We request you to kindly take the same on your record.
31-01-2020
Bigul

Alembic sees India sales recovering from Q1FY21, expects 10-12% growth

This financial year should see 15-20 product launches in the US
26-01-2020
Bigul

ALEMBIC LTD. - 506235 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of Notice of Board Meeting published in English and vernacular language (Gujarati) newspapers on 24th January, 2020 in Indian Express and Financial Express. We request you to please take the same on record.
24-01-2020
Bigul

ALEMBIC LTD. - 506235 - Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December, 2019

ALEMBIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2020 ,inter alia, to consider and approve With reference to the captioned matter, the Exchange is hereby informed that a Meeting of Board of Directors of the Company will be held on Friday, 31st January, 2020, inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and nine months period ended 31st December, 2019. Pursuant to the Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st January, 2020, will reopen 48 hours after the declaration of the financial results on 31st January, 2020. Kindly take note of the above.
23-01-2020
Bigul

ALEMBIC LTD. - 506235 - Shareholding for the Period Ended December 31, 2019

Alembic Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
16-01-2020

Alembic gets USFDA nod for Vilazodone Hydrochloride tablets used to treat depression

"The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Vilazodone Hydrochloride tablets, 10 mg, 20 mg, and 40 mg," Alembic said in a filing to BSE.
13-01-2020
Bigul

ALEMBIC LTD. - 506235 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate(s) of the Company as mentioned int the attached file, has been reported as lost/misplaced and the shareholder of such lost share certificate(s) have requested the Company for issue of duplicate share certificate(s). Also find attached herewith the letter received from RTA as a proof of date of receipt of information by the Company. We request you to kindly take the same on record.
08-01-2020
Bigul

Alembic Ltd - 506235 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

With reference to the captioned matter, please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2019, received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of our Company. We request you to kindly take the same on record.
06-01-2020
Next Page
Close

Let's Open Free Demat Account